Therefore, we next assessed the correlation of KRT15 and KRT19 expression with overall survival in the Metastatic Prostate Adenocarcinoma (SU2C/PCF Dream Team) patient cohort. The gene discussed is KRT15; the disease is prostate adenocarcinoma.